Steven Cohen Cybin Inc. Transaction History
Point72 Asset Management, L.P.
- $39.3 Billion
- Q1 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Cybin Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 13,664,080 shares of CYBN stock, worth $3.55 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,664,080
Previous 30,061,112
54.55%
Holding current value
$3.55 Million
Previous $12.3 Million
54.55%
% of portfolio
0.01%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding CYBN
# of Institutions
108Shares Held
243MCall Options Held
0Put Options Held
0-
Deep Track Capital, LP Greenwich, CT58.1MShares$15.1 Million0.79% of portfolio
-
Logos Global Management LP San Francisco, CA40MShares$10.4 Million1.53% of portfolio
-
Avidity Partners Management LP Dallas, TX34.9MShares$9.07 Million0.55% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L325.6MShares$6.65 Million1.64% of portfolio
-
Octagon Capital Advisors LP New York, NY18.6MShares$4.84 Million1.19% of portfolio
About CYBIN INC.
- Ticker CYBN
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 166,120,000
- Market Cap $43.2M
- Description
- Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...